z-logo
open-access-imgOpen Access
Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
Author(s) -
Kamonpan Sanachai,
Tuanjai Somboon,
Patcharin Wilasluck,
Peerapon Deetanya,
Peter Wolschann,
Thierry Langer,
Vannajan Sanghiran Lee,
Kittikhun Wangkat,
Thanyada Rungrotmongkol,
Supot Hangbua
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0269563
Subject(s) - pharmacophore , virtual screening , drug repositioning , lapatinib , pharmacology , repurposing , computational biology , drug discovery , in silico , peptidomimetic , protease , docking (animal) , lipinski's rule of five , drug , chemistry , enzyme , medicine , biology , biochemistry , genetics , breast cancer , gene , peptide , ecology , trastuzumab , nursing , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom